Zoetis Inc (ZTS) Position Cut by Investec Asset Management LTD
Investec Asset Management LTD cut its position in shares of Zoetis Inc (NYSE:ZTS) by 82.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 38,111 shares of the company’s stock after selling 180,256 shares during the period. Investec Asset Management LTD’s holdings in Zoetis were worth $2,746,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. BlackRock Inc. boosted its holdings in Zoetis by 3.8% during the fourth quarter. BlackRock Inc. now owns 38,485,542 shares of the company’s stock worth $2,772,498,000 after buying an additional 1,394,156 shares in the last quarter. Brown Advisory Inc. boosted its holdings in Zoetis by 2.1% during the fourth quarter. Brown Advisory Inc. now owns 7,207,114 shares of the company’s stock worth $519,200,000 after buying an additional 149,095 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in Zoetis by 1.5% during the third quarter. Janus Henderson Group PLC now owns 5,893,853 shares of the company’s stock worth $375,792,000 after buying an additional 84,767 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in Zoetis by 4.7% during the fourth quarter. Wells Fargo & Company MN now owns 5,313,643 shares of the company’s stock worth $382,795,000 after buying an additional 238,061 shares in the last quarter. Finally, Polen Capital Management LLC acquired a new position in Zoetis during the fourth quarter worth $285,967,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Zoetis Inc (NYSE:ZTS) opened at $81.28 on Monday. Zoetis Inc has a 12-month low of $52.25 and a 12-month high of $83.46. The stock has a market cap of $39,610.00, a PE ratio of 37.28, a P/E/G ratio of 1.83 and a beta of 0.97. The company has a debt-to-equity ratio of 2.77, a quick ratio of 2.55 and a current ratio of 3.85.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Investors of record on Friday, April 20th will be given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.62%. The ex-dividend date is Thursday, April 19th. Zoetis’s payout ratio is currently 22.94%.
A number of equities analysts have weighed in on ZTS shares. BidaskClub upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. Jefferies Group restated a “buy” rating on shares of Zoetis in a research report on Friday, November 10th. Cowen set a $80.00 price objective on shares of Zoetis and gave the stock a “buy” rating in a research report on Friday, November 17th. UBS Group restated a “neutral” rating on shares of Zoetis in a research report on Friday, November 24th. Finally, Morgan Stanley upgraded shares of Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 price objective for the company in a research report on Wednesday, November 29th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Zoetis currently has an average rating of “Buy” and a consensus price target of $80.28.
In related news, insider Heidi C. Chen sold 37,453 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $81.02, for a total transaction of $3,034,442.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Roxanne Lagano sold 35,663 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $81.02, for a total transaction of $2,889,416.26. Following the sale, the executive vice president now owns 49,919 shares of the company’s stock, valued at $4,044,437.38. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 97,001 shares of company stock valued at $7,882,428. 0.31% of the stock is owned by company insiders.
ILLEGAL ACTIVITY NOTICE: “Zoetis Inc (ZTS) Position Cut by Investec Asset Management LTD” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/zoetis-inc-zts-position-cut-by-investec-asset-management-ltd/1909204.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.